Get Started

OMER

NASD Omeros Corporation
Nov 8, 2026 · 11:16 PM ET EOD Market Closed

$16.92 ↑ +0.00 (+0.00%) Trading Up from the previous close of $16.92, $0.43 below the day’s high of $17.35

YTD change
-1.48%
vs 20-day SMA
-4.61%
vs 200-day SMA
+24.41%

Price ranges

Previous day
$16.64 $17.35
open $17.26 close $16.92
-$0.34 (-1.97%)
Today
$16.64 $17.35
$16.92
Past week
$16.97 $19.01
from $18.95 now $16.92
-$2.03 (-10.71%)
Past month
$15.85 $20.24
from $19.12 now $16.92
-$2.20 (-11.51%)
This year
$6.70 $21.24
from $17.18 now $16.92
-$0.25 (-1.48%)

Price & Performance

+2.79 (+19.75%) / 6M

$7.68$12.47$17.25$22.04May 8Aug 10Nov 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 37.5% away from all-time highs of $27.09
  • OMER is down 1% since the beginning of the year
  • OMER is up 157% over the past 12 months
  • OMER is down 12% over the past 1 month
  • 18% of all OMER investors are betting against OMER

OMER reads neutral: price sits above one of the two key moving averages, the 12-month move is +156.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.15
Earnings momentum -650.0% Quarterly EPS growth
Quarterly change -650.0%

Valuation

P/E ratio 10.57
Enterprise value $1.7B
Beta 3.92

Balance sheet & scale

Income$116.5K
Revenue$38.4M
Cash$132.0M
Debt$296.9K
Income / Debt 0.39×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.2B

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $460.42 +0.03%
MRNA Moderna, Inc. $254.19 +5.27%
RVMD Revolution Medicines, Inc. $192.28 +8.24%
ROIV Roivant Sciences Ltd. $38.88 +6.17%
BNTX BioNTech SE Sponsored ADR $87.51 +1.92%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.